Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Saint-Gobain Formula is a Saint-Gobain group business focused on high-performance industrial plaster and gypsum products. The company supplies specialty gypsum-based materials across multiple end markets including construction materials, ceramics, fibrous and decorative plaster, food, agriculture and environment, and dental and personal care. While it has products used in dental laboratories, it is not a biotech or pharmaceutical therapeutics company and does not appear to run a drug-development pipeline. The business was founded in 1997 from the combination of the industrial plaster activities of Börgardts, British Gypsum, Iberyeso and Plâtres Lambert, and operates as a specialist gypsum brand within Saint-Gobain. Its value proposition centers on customized, high-quality and sustainable gypsum solutions for industrial customers worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Saint-Gobain Formula.